Poly(ADP-RIBOSE)polymerase-1 (Parp-1) antagonizes topoisomerase 1-dependent recombination stimulation by P53

被引:22
|
作者
Baumann, C
Boehden, GS
Bürkle, A
Wiesmüller, L
机构
[1] Univ Frauen Klin, D-89075 Ulm, Germany
[2] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany
[3] Univ Konstanz, Dept Biol, Mol Toxicol Grp, D-78457 Constance, Germany
关键词
D O I
10.1093/nar/gkj509
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PARP-1 interacts with and poly(ADP-ribosyl)ates p53 and topoisomerase 1, which both participate in DNA recombination. Previously, we showed that PARP-1 downregulates homology-directed double-strand break (DSB) repair. We also discovered that, despite the well-established role of p53 as a global suppressor of error-prone recombination, p53 enhances homologous recombination (HR) at the RAR alpha breakpoint cluster region (bcr) comprising topoisomerase I recognition sites. Using an SV40-based assay and isogenic cell lines differing in the p53 and PARP-1 status we demonstrate that PARP-1 counteracts HR enhancement by p53, although DNA replication was largely unaffected. When the same DNA element was integrated in an episomal recombination plasmid, both p53 and PARP-1 exerted anti-recombinogenic rather than stimulatory activities. Strikingly, with DNA substrates integrated into cellular chromosomes, enhancement of HR by p53 and antagonistic PARP-1 action was seen, very similar to the HR of viral minichromosomes. siRNA-mediated knockdown revealed the essential role of topoisomerase I in this regulatory mechanism. However, after I-Scel-meganuclease-mediated cleavage of the chromosomally integrated substrate, no topoisomerase I-dependent effects by p53 and PARP-1 were observed. Our data further indicate that PARP-1, probably through topoisomerase I interactions rather than poly(ADP-ribosyl)ation, prevents p53 from stimulating spontaneous HR on chromosomes via topoisomerase I activity.
引用
收藏
页码:1036 / 1049
页数:14
相关论文
共 50 条
  • [31] Poly (Adp-Ribose) Polymerase-1 (PARP-1) Is a Good Prognostic Marker for Pancreatic/Periampullary Cancers
    Yim, Kwangil
    Seo, Kyung Jin
    Abdul-Ghafar, Jamshid
    Alam, Mohammad Rizwan
    Paik, Kwang Yeol
    Chong, Yosep
    Shin, Ok Ran
    PANCREAS, 2024, 53 (08) : e681 - e688
  • [32] Poly(ADP-ribose) polymerase-1 (Parp-1)-deficient mice demonstrate abnormal antibody responses
    Ambrose, Helen E.
    Willimott, Shaun
    Beswick, Richard W.
    Dantzer, Francoise
    de Murcia, Josiane Menissier
    Yelamos, Jose
    Wagner, Simon D.
    IMMUNOLOGY, 2009, 127 (02) : 178 - 186
  • [33] Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy
    Helleday, T
    Bryant, HE
    Schultz, N
    CELL CYCLE, 2005, 4 (09) : 1176 - 1178
  • [34] Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination
    Schultz, N
    Lopez, E
    Saleh-Gohari, N
    Helleday, T
    NUCLEIC ACIDS RESEARCH, 2003, 31 (17) : 4959 - 4964
  • [35] Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage
    Moroni, Flavio
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (01) : 96 - 103
  • [36] Alpha-synuclein inhibits poly (ADP-ribose) polymerase-1 (PARP-1) activity via NO-dependent pathway
    Adamczyk, Agata
    Kazmierczak, Anna
    FOLIA NEUROPATHOLOGICA, 2009, 47 (03) : 247 - 251
  • [37] Inhibition of poly (ADP-ribose) polymerase-1 (PARP-1) as a strategy for targeted therapy in Ewing's sarcoma
    Brenner, J. Chad
    Feng, Felix Y.
    Han, Sumin
    Bou-Maroun, Laura M.
    Patel, Sonam
    Goyal, Siddharth V.
    Liu, Meilan
    Lonigro, Robert
    Prensner, John R.
    Tomlins, Scott A.
    Chinnaiyan, Arul M.
    CANCER RESEARCH, 2012, 72
  • [38] Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease
    Infante, Jon
    Sanchez-Juan, Pascual
    Mateo, Ignacio
    Rodriguez-Rodriguez, Eloy
    Sanchez-Quintana, Coro
    Llorca, Javier
    Fontalba, Ana
    Terrazas, Jesus
    Oterino, Agustin
    Berciano, Jose
    Combarros, Onofre
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 256 (1-2) : 68 - 70
  • [39] MEDI 303-Design and synthesis of novel inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)
    Patel, Maulik R.
    Pino, Maria
    Billack, Blase
    Talele, Tanaji T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [40] Production, extraction, and purification of human poly(ADP-ribose) polymerase-1 (PARP-1) with high specific activity
    Knight, MI
    Chambers, PJ
    PROTEIN EXPRESSION AND PURIFICATION, 2001, 23 (03) : 453 - 458